Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart

R. A. Evans, M. Watson, H. I. Yamamura, W. R. Roeske

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Studies with [3H]pirenzepine ([3H]PZ) suggest that this nonclassical muscarinic antagonist selectively identifies putative M1 muscarinic receptors. We now compare the ontogeny of these putative M1 sites, identified by high-affinity [3H]PZ binding, with sites identified by the classical antagonist (-)-[3H]quinuclidinyl benzilate {(-)-[3h]QNB}) in murine cerebral cortical and cardiac homogenates. Dissociation constants (K(d)) for [3H]PZ (2.1-6 nM in the cortex and 2.0-21 nM in the heart) and for (-)-[3H]QNB (10-28 pM in the cortex and 10-39 pM in the heart) are similar in adult and neonatal tissues, whereas receptor density (maximum binding, femtomoles per milligram of protein) varies significantly. Cerebral cortical [3H]PZ binding rises from 14% at birth, to 88% of adult levels by day 14, peaks at 128% at day 28 and falls to the mean adult level of 606 fmol/mg of protein. Cerebral cortical (-)[3H]QNB binding parallels [3H]PZ binding. Conversely, parallel studies show cardiac (-)-[3H]QNB density is 3- to 17-fold greater than the comparable density of high-affinity [3H]PZ binding sites throughout ontogeny. We conclude that: 1) the high ratio of [3H]PZ binding to (-)-[3H]QNB binding identifies the murine cerebral cortex as a tissue which contains predominantly putative M1 muscarinic binding sites; 2) the relatively low ratio of [3H]PZ binding to (-)-[3H]QNB binding throughout ontogeny identifies the murine heart as a tissue which contains primarily the putative M2 muscarinic binding site; and 3) M1 and M2 receptor binding sites show distinct developmental curves in the cerebral cortex and heart. In the postnatal period, cerebral cortical M1 receptor density rises rapidly whereas cardiac M2 density shows little change. These data support the concept of distinct muscarinic receptor subtypes.

Original languageEnglish (US)
Pages (from-to)612-618
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume235
Issue number3
StatePublished - 1985
Externally publishedYes

Fingerprint

Muscarinic M2 Receptors
Muscarinic M1 Receptors
Cerebral Cortex
Binding Sites
Cholinergic Agents
Quinuclidinyl Benzilate
Pirenzepine
Muscarinic Antagonists
Muscarinic Receptors
Proteins
Parturition

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. / Evans, R. A.; Watson, M.; Yamamura, H. I.; Roeske, W. R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 235, No. 3, 1985, p. 612-618.

Research output: Contribution to journalArticle

@article{0f50fd48d50a412192c59690051a4cf9,
title = "Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart",
abstract = "Studies with [3H]pirenzepine ([3H]PZ) suggest that this nonclassical muscarinic antagonist selectively identifies putative M1 muscarinic receptors. We now compare the ontogeny of these putative M1 sites, identified by high-affinity [3H]PZ binding, with sites identified by the classical antagonist (-)-[3H]quinuclidinyl benzilate {(-)-[3h]QNB}) in murine cerebral cortical and cardiac homogenates. Dissociation constants (K(d)) for [3H]PZ (2.1-6 nM in the cortex and 2.0-21 nM in the heart) and for (-)-[3H]QNB (10-28 pM in the cortex and 10-39 pM in the heart) are similar in adult and neonatal tissues, whereas receptor density (maximum binding, femtomoles per milligram of protein) varies significantly. Cerebral cortical [3H]PZ binding rises from 14{\%} at birth, to 88{\%} of adult levels by day 14, peaks at 128{\%} at day 28 and falls to the mean adult level of 606 fmol/mg of protein. Cerebral cortical (-)[3H]QNB binding parallels [3H]PZ binding. Conversely, parallel studies show cardiac (-)-[3H]QNB density is 3- to 17-fold greater than the comparable density of high-affinity [3H]PZ binding sites throughout ontogeny. We conclude that: 1) the high ratio of [3H]PZ binding to (-)-[3H]QNB binding identifies the murine cerebral cortex as a tissue which contains predominantly putative M1 muscarinic binding sites; 2) the relatively low ratio of [3H]PZ binding to (-)-[3H]QNB binding throughout ontogeny identifies the murine heart as a tissue which contains primarily the putative M2 muscarinic binding site; and 3) M1 and M2 receptor binding sites show distinct developmental curves in the cerebral cortex and heart. In the postnatal period, cerebral cortical M1 receptor density rises rapidly whereas cardiac M2 density shows little change. These data support the concept of distinct muscarinic receptor subtypes.",
author = "Evans, {R. A.} and M. Watson and Yamamura, {H. I.} and Roeske, {W. R.}",
year = "1985",
language = "English (US)",
volume = "235",
pages = "612--618",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart

AU - Evans, R. A.

AU - Watson, M.

AU - Yamamura, H. I.

AU - Roeske, W. R.

PY - 1985

Y1 - 1985

N2 - Studies with [3H]pirenzepine ([3H]PZ) suggest that this nonclassical muscarinic antagonist selectively identifies putative M1 muscarinic receptors. We now compare the ontogeny of these putative M1 sites, identified by high-affinity [3H]PZ binding, with sites identified by the classical antagonist (-)-[3H]quinuclidinyl benzilate {(-)-[3h]QNB}) in murine cerebral cortical and cardiac homogenates. Dissociation constants (K(d)) for [3H]PZ (2.1-6 nM in the cortex and 2.0-21 nM in the heart) and for (-)-[3H]QNB (10-28 pM in the cortex and 10-39 pM in the heart) are similar in adult and neonatal tissues, whereas receptor density (maximum binding, femtomoles per milligram of protein) varies significantly. Cerebral cortical [3H]PZ binding rises from 14% at birth, to 88% of adult levels by day 14, peaks at 128% at day 28 and falls to the mean adult level of 606 fmol/mg of protein. Cerebral cortical (-)[3H]QNB binding parallels [3H]PZ binding. Conversely, parallel studies show cardiac (-)-[3H]QNB density is 3- to 17-fold greater than the comparable density of high-affinity [3H]PZ binding sites throughout ontogeny. We conclude that: 1) the high ratio of [3H]PZ binding to (-)-[3H]QNB binding identifies the murine cerebral cortex as a tissue which contains predominantly putative M1 muscarinic binding sites; 2) the relatively low ratio of [3H]PZ binding to (-)-[3H]QNB binding throughout ontogeny identifies the murine heart as a tissue which contains primarily the putative M2 muscarinic binding site; and 3) M1 and M2 receptor binding sites show distinct developmental curves in the cerebral cortex and heart. In the postnatal period, cerebral cortical M1 receptor density rises rapidly whereas cardiac M2 density shows little change. These data support the concept of distinct muscarinic receptor subtypes.

AB - Studies with [3H]pirenzepine ([3H]PZ) suggest that this nonclassical muscarinic antagonist selectively identifies putative M1 muscarinic receptors. We now compare the ontogeny of these putative M1 sites, identified by high-affinity [3H]PZ binding, with sites identified by the classical antagonist (-)-[3H]quinuclidinyl benzilate {(-)-[3h]QNB}) in murine cerebral cortical and cardiac homogenates. Dissociation constants (K(d)) for [3H]PZ (2.1-6 nM in the cortex and 2.0-21 nM in the heart) and for (-)-[3H]QNB (10-28 pM in the cortex and 10-39 pM in the heart) are similar in adult and neonatal tissues, whereas receptor density (maximum binding, femtomoles per milligram of protein) varies significantly. Cerebral cortical [3H]PZ binding rises from 14% at birth, to 88% of adult levels by day 14, peaks at 128% at day 28 and falls to the mean adult level of 606 fmol/mg of protein. Cerebral cortical (-)[3H]QNB binding parallels [3H]PZ binding. Conversely, parallel studies show cardiac (-)-[3H]QNB density is 3- to 17-fold greater than the comparable density of high-affinity [3H]PZ binding sites throughout ontogeny. We conclude that: 1) the high ratio of [3H]PZ binding to (-)-[3H]QNB binding identifies the murine cerebral cortex as a tissue which contains predominantly putative M1 muscarinic binding sites; 2) the relatively low ratio of [3H]PZ binding to (-)-[3H]QNB binding throughout ontogeny identifies the murine heart as a tissue which contains primarily the putative M2 muscarinic binding site; and 3) M1 and M2 receptor binding sites show distinct developmental curves in the cerebral cortex and heart. In the postnatal period, cerebral cortical M1 receptor density rises rapidly whereas cardiac M2 density shows little change. These data support the concept of distinct muscarinic receptor subtypes.

UR - http://www.scopus.com/inward/record.url?scp=0022403737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022403737&partnerID=8YFLogxK

M3 - Article

C2 - 3841156

AN - SCOPUS:0022403737

VL - 235

SP - 612

EP - 618

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -